IP Library Assignment 064095/0350
Patent Assignment
Reel/Frame 064095/0350

Assignment of Assignor's Interest

Recorded: 2023-06-28 Pages: 4
Assignor
HALLORAN, KEVIN JOHN
Executed: 2010-11-01
Assignee
ATON PHARMA, INC.
3150 BRUNSWICK PIKE, SUITE 230, LAWRENCEVILLE, NEW JERSEY, 08648
Covered Property (1)
Ocular Drug Delivery Devices
Application: 16/241,558 →
Publication: US 2019/0133934
Related Assignments (16)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Intellectual Property Security Agreement Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Security Interest Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Merger Jun 28, 2023
From: ATON PHARMA, INC.
To: PRINCETON PHARMA HOLDINGS, LLC
Reel/Frame 064095/0682 →
Change of Name Jun 28, 2023
From: VALEANT PHARMACEUTICALS INTERNATIONAL
To: BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 064150/0586 →
Merger Jun 28, 2023
From: PRINCETON PHARMA HOLDINGS, LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL
Reel/Frame 064097/0147 →
Assignment of Assignor's Interest Jan 24, 2024
From: BAUSCH HEALTH AMERICAS, INC.
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 066225/0445 →
Omnibus Patent Security Release Agreement (Reel/Frame 049672/0652) Apr 17, 2024
From: THE BANK OF NEW YORK MELLON
To: BAUSCH + LOMB IRELAND LIMITED; BAUSCH + LOMB CORPORATION
Reel/Frame 067131/0618 →
Omnibus Patent Security Release Agreement (Reel/Frame 057821/0800) Apr 17, 2024
From: THE BANK OF NEW YORK MELLON
To: BAUSCH + LOMB IRELAND LIMITED; BAUSCH + LOMB CORPORATION
Reel/Frame 067131/0651 →
Omnibus Patent Security Release Agreement (Reel/Frame 048556/0758) Apr 17, 2024
From: THE BANK OF NEW YORK MELLON
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 067131/0607 →
Intellectual Property Security Agreement May 22, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 067501/0955 →
Intellectual Property Security Agreement May 23, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 067527/0251 →
Patent Security Agreement Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
Assignment of Security Interest in Patents Previously Recorded at Reel/Frame (067501/0955) Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072460/0665 →
Release of Security Interest Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 073637/0222 →
Release of Security Interest Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
Reel/Frame 073637/0126 →